Cleared Traditional

K912489 - COLORZYME EBV EARLY ANTIGEN IGG ANTIBOD...

K912489 is the FDA 510(k) clearance for COLORZYME EBV EARLY ANTIGEN IGG ANTIBOD... by Immuno Concepts, Inc.. It is a Class 1 Microbiology device (product code LSE) cleared through the Traditional 510(k) pathway after a 50-day FDA review.

K912489 · Immuno Concepts, Inc. · Microbiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jul 1991
Decision
50d
Days
Class 1
Risk

K912489 is an FDA 510(k) clearance for the COLORZYME EBV EARLY ANTIGEN IGG ANTIBODY TEST SYS. Classified as Epstein-barr Virus, Other (product code LSE), Class I - General Controls.

Submitted by Immuno Concepts, Inc. (Sacramento, US). The FDA issued a Cleared decision on July 24, 1991 after a review of 50 days - a notably fast clearance cycle.

This device falls under the Microbiology FDA review panel, regulated under 21 CFR 866.3235 - the FDA microbiology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Immuno Concepts, Inc. devices

Submission Details

510(k) Number K912489 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received June 04, 1991
Decision Date July 24, 1991
Days to Decision 50 days
Submission Type Traditional
Review Panel Microbiology (MI)
Summary Statement
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
52d faster than avg
Panel avg: 102d · This submission: 50d
Pathway characteristics
Predicate-based equivalence.

Device Classification

Product Code LSE Epstein-barr Virus, Other
Device Class Class 1 - General Controls
CFR Regulation 21 CFR 866.3235
What this classification means

Class I devices are subject to general controls only and most are exempt from 510(k) premarket notification. They represent the lowest regulatory burden in the FDA device framework.

Regulatory Peers - LSE Epstein-barr Virus, Other

All 23
Devices cleared under the same product code (LSE) and FDA review panel - the closest regulatory comparables to K912489.
EPSTEIN-BARR VIR EARLY ANTI DIFF IGG CLIN-ELISA
K921628 · Incstar Corp. · Sep 1992
BARTELS EPSTEIN-BARR VIRUS IGG EIA
K922332 · Baxter Diagnostics, Inc. · Sep 1992
FLUORECENT EBV-EARLY ANTIGEN IGG ANTIBODY TEST SYS
K912488 · Immuno Concepts, Inc. · Jul 1991
EPSTEIN-BARR VIRUS EARLY ANTIGEN (EA) ANTIBODY TES
K882447 · Zeus Scientific, Inc. · Dec 1988
EBV-EA TEST
K872617 · Gull Laboratories, Inc. · Jan 1988